Safety of low dose heparin in elective coronary angioplasty (Q36844130)

16 August 2017

Safety of low dose heparin in elective coronary angioplasty (English)

1 reference

16 August 2017

1 reference

1 reference

7

Lie KI

1 reference

16 August 2017

Koch KT

1

1 reference

16 August 2017

Piek JJ

2

1 reference

16 August 2017

de Winter RJ

3

1 reference

16 August 2017

David GK

4

1 reference

16 August 2017

Mulder K

5

1 reference

16 August 2017

Tijssen JG

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

16 August 2017

1 reference

16 August 2017

77

1 reference

16 August 2017

6

1 reference

16 August 2017

517-522

1 reference

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Lesion morphology and coronary angioplasty: current experience and analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Current complications of diagnostic and therapeutic cardiac catheterization

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Adequate heparinization during PTCA: assessment using activated clotting times

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484793

Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols

27 June 2018

1 reference

12 December 2020

Relation between activated clotting time during angioplasty and abrupt closure

1 reference

12 December 2020

Acute coronary occlusion occurring after successful percutaneous transluminal coronary angioplasty: temporal relationship to discontinuation of anticoagulation

1 reference

12 December 2020

Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty

1 reference

12 December 2020

Unstable angina. A classification

1 reference

12 December 2020

Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty

1 reference

12 December 2020

Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures

1 reference

12 December 2020

The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparin

1 reference

12 December 2020

Is aggressive heparinization necessary for elective PTCA?

1 reference

12 December 2020

A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group

1 reference

12 December 2020

Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Activated clotting times in acute coronary syndromes and percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device

1 reference

12 December 2020

Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)

1 reference

12 December 2020

Low-dose heparin for routine coronary angioplasty and stenting

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.77.6.517

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

9227294

1 reference